SLAYEN HOWARD T sold $758K of AEHR

SLAYEN HOWARD T (Director) sold 5,700 shares of AEHR TEST SYSTEMS (AEHR) at $133.03 ($0.76M total) on 2026-08-14.

Original reporting
SEC EDGAR · SLAYEN HOWARD T
Published Aug 14, 2026, 9:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior but does not disclose new operational, financial, or regulatory information about AEHR.

02

Market read

Traders may briefly reassess sentiment around AEHR due to insider selling, but there is no fundamental catalyst in the text.

03

What to watch

The filing does not state motivations, and the transaction is an open-market sale. Also, insider selling can occur alongside positive fundamentals, so traders should watch for follow-on Form 4 patterns rather than react once.

Relevance 5/10Novelty 3/10Timing: filed on 2026-08-14, after-hours SEC Form 4 disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for AEHR, reported as an open-market sale by a director.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

Director Slayen Howard T filed an open-market sale of 5,700 AEHR shares for about $758K on 2026-08-14.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and should fade unless follow-on selling appears.

Evidence & confidence

The filing is a Form 4 insider transaction, but it does not include new company fundamentals, guidance, or regulatory/contract events. The absence of a 10b5-1 plan can increase interpretive noise, yet the disclosed size is not large enough to imply a structural shift by itself.

Market effects

No clear sector read-through; this is company-specific insider activity without operational or regulatory linkage.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity or diversification; without evidence of broader selling or performance deterioration, the signal may be overstated.

Key entities

  • AEHR TEST SYSTEMS

    Subject of the Form 4 insider transaction disclosure.

  • SLAYEN HOWARD T

    Director who sold 5,700 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.